Specify a stock or a cryptocurrency in the search bar to get a summary
Oncosil Medical Ltd
OSLOncoSil Medical Limited, a medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in Australia, New Zealand, and Europe. Its lead product is OncoSil, a single-use brachytherapy device for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia. Address: 7 Eden Park Drive, Macquarie Park, NSW, Australia, 2113
Analytics
WallStreet Target Price
0.092 AUDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures OSL
Dividend Analytics OSL
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History OSL
Stock Valuation OSL
Financials OSL
Results | 2019 | Dynamics |